Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT06354738

Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assessment

Led by University Hospital, Gasthuisberg · Updated on 2024-04-17

1000

Participants Needed

1

Research Sites

302 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Gasthuisberg

Lead Sponsor

F

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Collaborating Sponsor

AI-Summary

What this Trial Is About

EUGENIE is a prospective multicentre interventional study, focused on improving endometrial cancer (EC) assessment by combining the new technique of genomic profiling with surgical extra uterine disease assessment. The investigators aim to correlate EC stage to each of the molecular subgroups of disease and thereby guide surgical treatment and staging of EC by determining the association between molecular classification and disease stage and evaluating if and how disease stage in each of the molecular subgroups associates with prognosis.

CONDITIONS

Official Title

Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assessment

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Voluntary written informed consent obtained before screening
  • Female participants aged 18 years or older
  • First diagnosis of endometrial cancer, any stage or histologic type
Not Eligible

You will not qualify if you...

  • History of pelvic or para-aortic lymph node dissection or sampling
  • Previous pelvic or para-aortic radiotherapy
  • Previous neoadjuvant chemotherapy
  • Any condition that might risk participant safety or study compliance as judged by the investigator
  • Any prior or current treatments that might compromise participant safety or study integrity

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

UZ Gasthuisberg, Katholieke Universiteit Leuven

Leuven, Belgium, 3000

Actively Recruiting

Loading map...

Research Team

F

Frédéric Amant, MD, PhD

CONTACT

A

Ayaka Wakatsuki, Msc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here